Review of the latest treatments for proliferative diabetic retinopathy

References

• Heng L, Comyn O, Peto T, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 2013;30(6):640-50
   PubMed Web of Science ®Google Scholar
• Antonetti D, Barber A, Bronson S, et al. Diabetic retinopathy seeing beyond glucose-induced microvascular disease. Diabetes 2006;55(9):2401-11
   PubMed Web of Science ®Google Scholar
• Gardner T, Antonetti D, Barber A, et al. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002;47(2):S253-62
   Google Scholar
• Al-Shabrawey M, Elsherbiny M, Nussbaum J, et al. Targeting neovascularization in ischemic retinopathy: recent advances. Expert Rev Ophthalmol 2013;8(3):267-86
   PubMedGoogle Scholar
• Tarr J, Kaul K, Chopra M, et al. Pathophysiology of diabetic retinopathy. ISRN Ophthalmol 2013;2013
   PubMedGoogle Scholar
• Stitt A, Curtis T. Advanced glycation and retinal pathology during diabetes. Pharmacol Rep 2005;57:156-68
   PubMed Web of Science ®Google Scholar
• Jain A, Saxena S, Khanna V, et al. Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol Vis 2013;19:1760-8
   PubMed Web of Science ®Google Scholar
• Lois N, McCarter R, O’Neill C, et al. Endothelial progenitor cells in diabetic retinopathy. Front Endocrinol 2014;5:44
   PubMedGoogle Scholar
• Curtis T, Gardiner T, Stitt A. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye 2009;23(7):1496-508
   PubMed Web of Science ®Google Scholar
• Antonetti D, Klein R, Gardner T. Diabetic Retinopathy. N Engl J Med 2012;366(13):1227-39
   PubMed Web of Science ®Google Scholar
• Kuiper E, Van Nieuwenhoven F, de Smet M, et al. The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One 2008;3(7):e2675
   Web of Science ®Google Scholar
• Mohan N, Monickaraj F, Balasubramanyam M, et al. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. J Diabetes Complications 2012;26(5):435-41
   PubMed Web of Science ®Google Scholar
• Watanabe D, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005;353(8):782-92
   PubMed Web of Science ®Google Scholar
• Wang J, Xu X, Elliott M, et al. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 2010;59(9):2297-305
   PubMed Web of Science ®Google Scholar
• Curtis T, Hamilton R, Yong P, et al. Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 2011;54(3):690-8
   PubMed Web of Science ®Google Scholar
• Li Q, Puro D. Diabetes-induced dysfunction of the glutamate transporter in retinal müller cells. Invest Ophthalmol Vis Sci 2002;43(9):3109-16
   PubMed Web of Science ®Google Scholar
• Bennett T, Barry C. Ophthalmic imaging today: an ophthalmic photographer’s viewpoint – a review. Clin Exp Ophthalmol 2009;37(1):2-13
   PubMed Web of Science ®Google Scholar
• Goatman K, Fleming A, Philip S, et al. Detection of new vessels on the optic disc using retinal photographs. IEE Trans Med Imaging 2011;30(4):972-9
   PubMed Web of Science ®Google Scholar
• Faust O, Acharya R, Ng E, et al. Algorithms for the automated detection of diabetic retinopathy using digital fundus images: a review. J Med Syst 2012;36(1):145-57
   PubMed Web of Science ®Google Scholar
• Keane P, Sadda S. Imaging chorioretinal vascular disease. Eye 2010;24(3):422-7
   PubMed Web of Science ®Google Scholar
• Ciresi A, Amato M, Morreale D, et al. OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. Acta Diabetol 2010;47(3):259-63
   PubMed Web of Science ®Google Scholar
• Oliver S, Schwartz S. Peripheral vessel leakage (PVL): a new angiographic finding in diabetic retinopathy identified with ultra wide-field fluorescein angiography. Semin Ophthalmol 2010;25(1-2):27-33
   PubMed Web of Science ®Google Scholar
• Bernardes R, Serranho P, Lobo C. Digital ocular fundus imaging: a review. Ophthalmologica 2011;226(4):161-81
   PubMed Web of Science ®Google Scholar
• Kalogeromitros D, Makris M, Aggelides X, et al. Allergy skin testing in predicting adverse reactions to fluorescein: a prospective clinical study. Acta Ophthalmol (Copenh) 2011;89(5):480-3
   Web of Science ®Google Scholar
• Zvornicanin J, Jusufovic V, Cabric E, et al. Significance of ultrasonography in evaluation of vitreo-retinal pathologies. Med Arh 2012;66(5):318-20
   Google Scholar
• Ahmed J, Shaikh F, Rizwan A, et al. Evaluation of vitreo-retinal pathologies using B-scan ultrasound. Pak J Ophthalmol 2009;25:4
   Google Scholar
• Silva P, Cavallerano J, Sun J, et al. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol 2012;154(3):549-59
   PubMed Web of Science ®Google Scholar
• Wessel M, Nair N, Aaker G, et al. Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol 2012;96(5):694-8
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Clinical retinopathy network. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. JAMA Ophthalmol 2013;131(3):283-93
   PubMed Web of Science ®Google Scholar
• Newman D. Surgical management of the late complications of proliferative diabetic retinopathy. Eye 2010;24(3):441-9
   PubMed Web of Science ®Google Scholar
• Crawford T, Alfaro D, Kerrison J, et al. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009;5(1):8-13
   PubMedGoogle Scholar
• Skarbez K, Priestley Y, Hoepf M, et al. Comprehensive review of the effects of diabetes on ocular health. Expert Rev Ophthalmol 2010;5(4):557-77
   PubMedGoogle Scholar
• Chu T, Lopez P, Cano M, et al. Posterior vitreoschisis: an echographic finding in proliferative diabetic retinopathy. Ophthalmology 1996;103(2):315-22
   PubMed Web of Science ®Google Scholar
• Brazitikos P, Stangos N. Macular hole formation in diabetic retinopathy: the role of coexisting macular edema. Documenta Ophthalmologica 1999;97(3-4):273-8
   PubMed Web of Science ®Google Scholar
• Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol 2008;246(3):329-32
   PubMed Web of Science ®Google Scholar
• Schwartz S, Alexander R, Hiscott P, et al. Recognition of vitreoschisis in proliferative diabetic retinopathy: a useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 1996;103(2):323-8
   PubMed Web of Science ®Google Scholar
• Kurihara T, Noda K, Ishida S, et al. Pars plana vitrectomy with internal limiting membrane removal for macular hole associated with proliferative diabetic Retinopathy. Graefes Arch Clin Exp Ophthalmol 2005;243(7):724-6
   PubMed Web of Science ®Google Scholar
• Flynn H. Macular hole surgery in patients with proliferative diabetic retinopathy. Arch Ophthalmol 1994;122(7):877-8
   Google Scholar
• Johnson M. Etiology and treatment of macular edema. Am J Ophthalmol 2009;147(1):11-21
   PubMed Web of Science ®Google Scholar
• Bhagat N, Grigorian R, Tutela A, et al. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009;54:1
   PubMed Web of Science ®Google Scholar
• Diep T, Tsui I. Risk factors associated with diabetic macular edema. Diabetes Res Clin Practice 2013;100(3):298-305
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson M, Lee K, et al. The Wisconsin epidemiologic study of diabetic retinopathy XXIII. The twenty-five-year incidence of macular edema in persons with Type 1 diabetes. Ophthalmology 2009;116(3):497-503
   PubMed Web of Science ®Google Scholar
• Klaassen I, Van Noorden C, Schlingemann R. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 2013;34:19-48
   PubMed Web of Science ®Google Scholar
• Stefánsson E. Diabetic macular edema. Saudi J Ophthalmol 2009;23(2):143-8
   PubMedGoogle Scholar
• Chan W, Tsai S, Wu A, et al. Current treatments of diabetic macular edema. Int J Gerontol 2011;5(4):183-8
   Web of Science ®Google Scholar
• Jeganathan V, Wang J, Wong T. Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care 2008;31(9):1905-12
   PubMed Web of Science ®Google Scholar
• Slagle W, Musick A, Eckermann D. Diabetic papillopathy and its relation to optic nerve ischemia. Optom Vis Sci 2009;86(4):E395-403
   Web of Science ®Google Scholar
• Kim M, Lee J, Lee S. Diabetic papillopathy with macular edema treated with intravitreal ranibizumab. Clin Ophthalmol 2013;7:2257-60
   PubMedGoogle Scholar
• Ostri C, Lund-Andersen H, Sander B, et al. Bilateral diabetic papillopathy and metabolic control. Ophthalmology 2010;117(11):2214-17
   PubMed Web of Science ®Google Scholar
• Willerslev A, Munch I, Larsen M. Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab. Acta Ophthalmol (Copenh) 2012;90(5):e407-9
   Web of Science ®Google Scholar
• Jiang Y, Liang X, Li X, et al. Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy. Acta Ophthalmol (Copenh) 2009;87(7):736-40
   Web of Science ®Google Scholar
• Vasudev D, Blair M, Galasso J, et al. Intravitreal bevacizumab for neovascular glaucoma. J Ocular Pharmacol Therapeutics 2009;25(5):453-8
   PubMed Web of Science ®Google Scholar
• Wolf A, Jagow B, Ulbig M, et al. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma. Ophthlmologica 2011;226(2):51-6
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008;115(9):1571-80
   PubMed Web of Science ®Google Scholar
• Velez-Montoya R, Guerrero-Naranjo J, Gonzalez-Mijares C, et al. Pattern scan laser photocoagulation: safety and complications, experience after 1301 consecutive cases. Br J Ophthalmol 2010;94(6):720-4
   PubMed Web of Science ®Google Scholar
• Aiello L, Sun J. Evidence-based data in the treatment of diabetic retinopathy. Johns Hopkins Advanced Studies in Ophthalmology 2008;5(1):22-9
   Google Scholar
• Abu El-Asrar A, Al-Mezaine H. Advances in the treatment of diabetic retinopathy. Saudi J Ophthalmol 2011;25(2):113-22
   PubMedGoogle Scholar
• Salam A, Mathew R, Sivaprasad S. Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Ophthalmol (Copenh) 2011;89(5):405-11
   Web of Science ®Google Scholar
• Filho J, Messias A, Almeida F, et al. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Acta Ophthalmol (Copenh) 2011;89(7):e567-72
   Web of Science ®Google Scholar
• Nicholson B, Schachat A. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010;248(7):915-30
   PubMed Web of Science ®Google Scholar
• Brouzas D, Charakidas A, Moschos M, et al. Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma. Clin Ophthalmol 2009;3:685-8
   PubMedGoogle Scholar
• Simó R, Hernández C. Advances in the medical treatment of diabetic retinopathy. Diabetes Care 2009;32(8):1556-62
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang Y, Zhao T, et al. vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab. Am J Ophthalmol 2012;153(2):307-13
   PubMed Web of Science ®Google Scholar
• Shin Y, Lee Y, Lee B, et al. Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy. Korean J Ophthalmol 2009;23(4):266-72
   PubMedGoogle Scholar
• Farahvash M, Majidi A, Roohipoor R, et al. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage. Retina 2011;31(7):1254-60
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez F, Gomez-Ulla F, Rodriguez-Cid M, et al. Triamcinolone and bevacizumab as adjunctive therapies to panretinal photocoagulation for proliferative diabetic retinopathy. ISRN Ophthalmol 2012;2012
   PubMedGoogle Scholar
• Arevalo J, Garcia-Amaris R. Intravitreal bevacizumab for diabetic retinopathy. Curr Diabetes Rev 2009;5(1):39-46
   PubMedGoogle Scholar
• Maia O Jr, Takahashi B, Costa R, et al. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol 2009;147(2):291-7
   PubMed Web of Science ®Google Scholar
• Ober M, Hariprasad S. Retinal lasers: past, present, and future. Retinal Physician Issue 2009;36-9
   Google Scholar
• Lock J, Fong K. Retinal laser photocoagulation. Med J Malaysia 2010;65(1):88-95
   PubMedGoogle Scholar
• Chhablani J, Mathai A, Rani P, et al. Comparison of conventional pattern and novel navigated panretinal photocoagulation in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2014;55(6):3432-8
   PubMed Web of Science ®Google Scholar
• Lin K, Lu S. Panretinal navigated laser photocoagulation for PDR. Retina Today 2014;65-70
   Google Scholar
• Chakrabarti R, Harper C, Keeffe J. Diabetic retinopathy management guidelines. Expert Rev Ophthalmol 2012;7(5):417-39
   Google Scholar
• González V, Giuliari G, Banda R, et al. Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy. Br J Ophthalmol 2009;39(11):1474-8
   Google Scholar
• Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117(6):1064-77
   PubMed Web of Science ®Google Scholar
• Kohno R, Hata Y, Mochizuki Y, et al. Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection. Am J Ophthalmol 2010;150(2):223-9
   PubMed Web of Science ®Google Scholar
• Ahmadieh H, Shoeibi N, Entezari M, et al. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients. Ophthalmology 2009;116(10):1943-8
   PubMed Web of Science ®Google Scholar
• Sharma S, Mahmoud T. Surgical management of proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina 2014;45(3):188-93
   PubMed Web of Science ®Google Scholar
• Gupta B, Sivaprasad S, Wong R, et al. Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK Study. Eye 2012;26(4):510-16
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Clinical Research Network. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 2010;117(6):1087-93
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Honda S, Tsukahara Y, et al. Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye 2009;23(1):108-11
   PubMed Web of Science ®Google Scholar
• Khuthaila M, Hsu J, Chiang A, et al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol 2013;155(4):757-63
   PubMed Web of Science ®Google Scholar
• Tao Y, Jiang Y, Li X, et al. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment. Retina 2010;30(3):447-51
   PubMed Web of Science ®Google Scholar
• Berrocal M. Novel techniques for diabetic vitrectomy. Retina Today 2013;36-8
   Web of Science ®Google Scholar
• Chen Y, Kuo H, Huang H. Retinal outcomes in proliferative diabetic retinopathy presenting during and after pregnancy. Chang Gung Med J 2004;27(9):678-84
   PubMedGoogle Scholar
• Pescosolido N, Campagna O, Barbato A. Diabetic retinopathy and pregnancy. Int Ophthalmol 2014;1-9
   Google Scholar
• Kuno N, Fujii S. Ocular drug delivery systems for the posterior segment: a review. Retina Today 2012;54-9
   PubMedGoogle Scholar
• Sanislo S, Palanker D, Vankov A, et al. Bubble-free plasma blade for posterior segment surgery. Invest Ophthalmol Vis Sci 2003;44(5):4877
   PubMedGoogle Scholar
• Silva P, Cavallerano J, Aiello L, et al. Telemedicine and diabetic retinopathy. Arch Ophthalmol 2011;129(2):236-42
   PubMedGoogle Scholar
• Ogunyemi O, George S, Patty L, et al. Teleretinal screening for diabetic retinopathy in six los angeles urban safety-net clinics: final study report. American Medical Informatics Association, Annual Symposium Proceedings 2013. 2013:1082-8
   Google Scholar